Arria and Glemser Leverage AI to Transform Clinical Trial Research
Are you leveraging technology the right way to bring scale, efficiency, and compliance to your clinical trials? The Arria and Glemser partnership presents a new way to use AI to
Are you leveraging technology the right way to bring scale, efficiency, and compliance to your clinical trials? The Arria and Glemser partnership presents a new way to use AI to
Industry news site TechTarget published an article about TIBCO’s push to enhance augmented intelligence capabilities to its analytics suite using technologies from both Microsoft and Arria. The article states: In
diginomica published an article featuring interviews with Sharon Daniels, CEO of Arria NLG, and Michael O’Connell, Chief Analytics Officer of TIBCO. The article states: TIBCO and Arria are using pandemic
SEE THE AREA 24 BEST PRACTICE LIST HERE > AREA 24 AREA 24 published their Best Practice list which features Arria NLG prominently right next to IBM’s Watson. Arria’s technology
IDG Connect published an article by Martin Veitch featuring the TIBCO + Arria COVID-19 dashboard collaboration including some key insights from Michael O’Connell, TIBCO’s chief analytics officer. The article states:
Recent article published by insideBIGDATA features an interview with Arria CEO, Sharon Daniels. The article states: Natural Language Generation (NLG) is rapidly becoming one of the most desired capabilities in
Industry news site Electronic Specifier published an article featuring Arria NLG titled, “AI helps clear up COVID-19 data.” The article covers how challenging it is for the average person to
NEW YORK, May 19, 2020 /PRNewswire/ – Arria NLG, a leading provider of Natural Language Generation (NLG) technology, today announced a collaboration with Glemser Technologies to bring scalable automation solutions
Forbes published an article by Arria CEO, Sharon Daniels, discussing how adding NLG narrative to complex data can immediately bring understanding. The article states: “As people and businesses around the